Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
- 21 March 2017
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (8) , 2259-2265
Abstract
This study was designed to determine the clinical significance of preoperative thrombocytosis in patients with malignant peritoneal mesothelioma (MPM) undergoing operative cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). CRS and HIPEC have been associated with prolonged survival in patients with MPM and is the preferred treatment in select patients. However, patient selection criteria remain ill-defined for this operation that is also associated with significant morbidity and mortality. Preoperative thrombocytosis has been associated with poor outcomes in various malignancies but never studied in MPM.Keywords
This publication has 29 references indexed in Scilit:
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysisAnnals of Surgical Oncology, 2014
- Current Trends in the Management of Malignant Peritoneal MesotheliomaAnnals of Surgical Oncology, 2014
- Prognostic factors influencing survival in 35 patients with malignant peritoneal mesotheliomaNeoplasma, 2014
- Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome AnalysisAnnals of Surgical Oncology, 2013
- Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesotheliomaSurgery, 2013
- Activation of the phosphoinositide‐3‐kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesotheliomaCancer, 2010
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005Cancer Causes & Control, 2009
- Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2003
- Peritoneal mesothelioma: natural history and response to chemotherapy.Journal of Clinical Oncology, 1983